Skip to main content

MEDICAL TOURISM FOREX EARNINGS TO GROW

ASSO/PR/527 May 26, 2008
MEDICAL TOURISM FOREX EARNINGS TO GROW RS. 8000 CR. FROM 2012 : ASSOCHAM
Easy access of Visa facilities often permitted by India to overseas patients coupled with best emerging medical infrastructure facilities in its large and tertiary towns, prospects of India Medical Tourism becoming a lead foreign exchange earners will grow to an extent of Rs. 8000 crore by 2012.
The above findings are arrived at The Associated Chambers of Commerce and Industry of India (ASSOCHAM) on Prospects of Medical Tourism for Higher Forex Earning' under the supervision of its Health Committee chaired by Chairman, Sir Ganga Ram Hospital, Dr. B K Rao in which other lead doctors from Medicity Moolchand, AIIMS, Max etc. are involved.
Releasing the ASSOCHAM estimates, its President, Mr. Venugopal N. Dhoot pointed out that currently, the earnings accrued through medical tourism annually are estimated at Rs.3500 crore.
"The primary reasons as to why medical tourism would flourish in India include much more lower medical costs for various ailments such as bone narrow transparent, bye-pass surgery, knee surgery and liver transplant as compared to western countries".
As a result of higher and very expensive medical costs in the western countries, patients from economies of scale including Africa, Gulf and various Asian countries have started exploring medical treatment in hospitals located in various well-to do places in India because its medical infrastructure has geared up to provide them non-subsidized medical treatment at much more lower costs which are many times considered reasonable, adds Mr. Dhoot.
The other reasons as to why India would emerge as a lead hub for excellent medical treatment is because of its strength of highly qualified medical professionals and even equally higher qualities of availability of nurses. India has about 7 lakh qualified doctors and numbers of qualified nursing graduates and diploma holders are equally good and of high professional caliber who are content and satisfied with reasonable professional feels.
A comparison of treatment costs is given in the tabulated form, comparing India's cost of medical treatment with countries such as USA, UK and Thailand :
Comparison of Treatment cost ($)
Medical Treatment
USA
UK
THAILAND
INDIA
Bone marrow transplant
More than 2,00,000
Up to2,00,000
Up to 62,500
Around20,000
Bye – pass Surgery
15,000- 20,000
Around 20,000
14, 250
4,000-6,000
Knee surgery
16000-17000
15,000
7,000
1,000
Liver transplant
300,000
2,50,000
750,000
4,000
This said Mr. Dhoot is the major advantage which works in favour of India as a result of which movement of patients from various developing and developed countries would shift towards India as its hospital infrastructure is not only confined to large metros but equally getting better in tertiary towns in which the cost of living is still lower with quality of supreme nature.
Still other reasons for medical tourism getting wide spread in India is because of its strength of traditional treatment in homeopathy, naturapathy, ayurvedic, unani etc. which are becoming popular because of their non-side effects, said Mr. Dhoot.
The Indian healthcare policy is getting adequately recongised from the policy makers as in India health spends in proportion to its GDP is about 1% which the government is gradually trying to increase. The increase in health GDP ratio would amount to proliferation of new health facilities as well as their centres for patients and such centres of excellence will finally be able to accommodate overseas patients as with increasing health facilities, its health infrastructure would still move for better and find acceptance in great deal of patients. Therefore, the prospects of medical tourism in India would be of super facilities and holds an excellent future, concluded Mr. Dhoot.
Source: Koteshwar Prasad Dobhal

Comments

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki